{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:31:55Z","timestamp":1784079115307,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijrobp.2018.01.096","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T17:37:51Z","timestamp":1517852271000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?"],"prefix":"10.1016","volume":"101","author":[{"given":"Bj\u00f8rg Y.","family":"Aksness\u00e6ther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Solberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olbj\u00f8rn H.","family":"Klepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor \u00c5ge","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Skovlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig Roth","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars J.","family":"Vatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-\u00c5smund","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.01.096_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): An open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ejca.2015.03.021","article-title":"Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study","volume":"51","author":"Thomsen","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia","volume":"60","author":"Tyrrell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","article-title":"Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3","volume":"61","author":"Widmark","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.juro.2010.03.137","article-title":"Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and\/or breast pain?","volume":"184","author":"Ozen","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/00365590601017329","article-title":"Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: Updated results from the Scandinavian Prostate Cancer Period Group-6 study after a median follow-up period of 7.1 years","volume":"40","author":"Iversen","year":"2006","journal-title":"Scand J Urol Nephrol"},{"issue":"5 Pt 1","key":"10.1016\/j.ijrobp.2018.01.096_bib9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","article-title":"Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: Results from the second analysis of the early prostate cancer program at median followup of 5.4 years","volume":"172","author":"Wirth","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib12","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3390\/ijerph9124744","article-title":"Second malignant neoplasms following radiotherapy","volume":"9","author":"Kumar","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/01.ju.0000056706.88960.7c","article-title":"Second primary cancers in men with prostate cancer: An increased risk of male breast cancer","volume":"169","author":"Thellenberg","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.juro.2006.03.036","article-title":"Breast cancer as a second primary in patients with prostate cancer\u2014Estrogen treatment or association with family history of cancer?","volume":"176","author":"Karlsson","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib15","first-page":"239269","article-title":"Prophylactic breast bud radiotherapy for patients taking bicalutamide: Should this still be practised for patients with prostate cancer?","volume":"2012","author":"Lewis","year":"2012","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib16","first-page":"781","article-title":"Malignant cystosarcoma phyllodes in a man treated with polyestradiolphosphate: Case report","volume":"152","author":"Johansson","year":"1986","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib17","first-page":"3433","article-title":"Male malignant phyllodes breast tumor after prophylactic breast radiotherapy and bicalutamide treatment: A case report","volume":"36","author":"Karihtala","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness","volume":"45","author":"Larsen","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib19","series-title":"International Classification of Disease for Oncology: ICD-O-3","year":"2013"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib21","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib22","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.clinimag.2015.07.025","article-title":"Extremely rare borderline phyllodes tumor in the male breast: A case report","volume":"39","author":"Kim","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/000313480306900916","article-title":"Cystosarcoma phyllodes tumors in men","volume":"69","author":"Konstantakos","year":"2003","journal-title":"Am Surg"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1067\/msy.2003.145","article-title":"Cystosarcoma phyllodes (phyllodes tumor) of the male breast","volume":"133","author":"Campagnaro","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.12876","article-title":"Phyllodes tumours of the breast: A consensus review","volume":"68","author":"Tan","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","article-title":"Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients","volume":"121","author":"Grantzau","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/bd-140393","article-title":"Recurrent phyllodes tumor in the male breast in a background of gynaecomastia","volume":"35","author":"Chougule","year":"2015","journal-title":"Breast Dis"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5152\/UCD.2015.3120","article-title":"Fibroadenoma in the male breast: Truth or myth?","volume":"32","author":"Agarwal","year":"2016","journal-title":"Turk J Surg"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib29","doi-asserted-by":"crossref","first-page":"e0136094","DOI":"10.1371\/journal.pone.0136094","article-title":"Gynecomastia in patients with prostate cancer: A systematic review","volume":"10","author":"Fagerlund","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7705\/biomedica.v36i3.2793","article-title":"Li-Fraumeni syndrome","volume":"36","author":"Ossa","year":"2016","journal-title":"Biomedica"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12885-017-3546-4","article-title":"Active smoking and risk of breast cancer in a Danish nurse cohort study","volume":"17","author":"Andersen","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.maturitas.2010.01.012","article-title":"Male breast cancer: An update in diagnosis, treatment and molecular profiling","volume":"65","author":"Onami","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.eururo.2014.01.003","article-title":"Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study","volume":"66","author":"Bancroft","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2018.01.096_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2007.04.023","article-title":"Genetic epidemiology of BRCA mutations\u2014Family history detects less than 50% of the mutation carriers","volume":"43","author":"Moller","year":"2007","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618302207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618302207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:28:48Z","timestamp":1693517328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618302207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0360301618302207"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.096","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}